Relationship  ||| S:0 E:13 ||| NN
Between  ||| S:13 E:21 ||| IN
Control  ||| S:21 E:29 ||| NNP
of  ||| S:29 E:32 ||| IN
Glycemia  ||| S:32 E:41 ||| NNP
and  ||| S:41 E:45 ||| CC
Gastric  ||| S:45 E:53 ||| NNP
Emptying  ||| S:53 E:62 ||| NNP
Disturbances  ||| S:62 E:75 ||| NNP
in  ||| S:75 E:78 ||| IN
Diabetes  ||| S:78 E:87 ||| NNP
Mellitus  ||| S:87 E:96 ||| NNP
Hyperglycemia  ||| S:96 E:110 ||| NNP
is  ||| S:110 E:113 ||| VBZ
implicated  ||| S:113 E:124 ||| VBN
as  ||| S:124 E:127 ||| IN
a  ||| S:127 E:129 ||| DT
major  ||| S:129 E:135 ||| JJ
risk  ||| S:135 E:140 ||| NN
factor  ||| S:140 E:147 ||| NN
for  ||| S:147 E:151 ||| IN
delayed  ||| S:151 E:159 ||| JJ
gastric  ||| S:159 E:167 ||| JJ
emptying  ||| S:167 E:176 ||| NN
in  ||| S:176 E:179 ||| IN
diabetes  ||| S:179 E:188 ||| JJ
mellitus  ||| S:188 E:197 ||| NN
and  ||| S:197 E:201 ||| CC
vice  ||| S:201 E:206 ||| FW
versa ||| S:206 E:211 ||| FW
.  ||| S:211 E:213 ||| .
However ||| S:213 E:220 ||| RB
,  ||| S:220 E:222 ||| ,
the  ||| S:222 E:226 ||| DT
extent  ||| S:226 E:233 ||| NN
to  ||| S:233 E:236 ||| TO
which  ||| S:236 E:242 ||| WDT
hyperglycemia  ||| S:242 E:256 ||| NNS
can  ||| S:256 E:260 ||| MD
affect  ||| S:260 E:267 ||| VB
gastric  ||| S:267 E:275 ||| JJ
emptying  ||| S:275 E:284 ||| NN
and  ||| S:284 E:288 ||| CC
vice  ||| S:288 E:293 ||| NN
versa  ||| S:293 E:299 ||| NNS
and  ||| S:299 E:303 ||| CC
the  ||| S:303 E:307 ||| DT
implications  ||| S:307 E:320 ||| NNS
for  ||| S:320 E:324 ||| IN
clinical  ||| S:324 E:333 ||| JJ
practice  ||| S:333 E:342 ||| NN
are  ||| S:342 E:346 ||| VBP
unclear ||| S:346 E:353 ||| JJ
.  ||| S:353 E:355 ||| .
We  ||| S:355 E:358 ||| PRP
systematically  ||| S:358 E:373 ||| VBP
reviewed  ||| S:373 E:382 ||| VBN
the  ||| S:382 E:386 ||| DT
evidence  ||| S:386 E:395 ||| NN
for  ||| S:395 E:399 ||| IN
this  ||| S:399 E:404 ||| DT
bidirectional  ||| S:404 E:418 ||| JJ
relationship  ||| S:418 E:431 ||| NN
and  ||| S:431 E:435 ||| CC
the  ||| S:435 E:439 ||| DT
effects  ||| S:439 E:447 ||| NNS
of  ||| S:447 E:450 ||| IN
pharmacotherapy  ||| S:450 E:466 ||| NN
for  ||| S:466 E:470 ||| IN
diabetes  ||| S:470 E:479 ||| NN
on  ||| S:479 E:482 ||| IN
gastric  ||| S:482 E:490 ||| JJ
emptying ||| S:490 E:498 ||| NN
.  ||| S:498 E:500 ||| .
Full-length  ||| S:500 E:512 ||| JJ
articles  ||| S:512 E:521 ||| NNS
investigating  ||| S:521 E:535 ||| VBG
the  ||| S:535 E:539 ||| DT
relationship  ||| S:539 E:552 ||| NN
between  ||| S:552 E:560 ||| IN
diabetes  ||| S:560 E:569 ||| JJ
mellitus  ||| S:569 E:578 ||| NN
and  ||| S:578 E:582 ||| CC
gastroparesis  ||| S:582 E:596 ||| NNS
were  ||| S:596 E:601 ||| VBD
reviewed  ||| S:601 E:610 ||| VBN
primarily  ||| S:610 E:620 ||| RB
to  ||| S:620 E:623 ||| TO
quantify  ||| S:623 E:632 ||| VB
the  ||| S:632 E:636 ||| DT
relationship  ||| S:636 E:649 ||| NN
between  ||| S:649 E:657 ||| IN
blood  ||| S:657 E:663 ||| NN
glucose  ||| S:663 E:671 ||| NN
concentrations  ||| S:671 E:686 ||| NNS
and  ||| S:686 E:690 ||| CC
gastrointestinal  ||| S:690 E:707 ||| JJ
sensorimotor  ||| S:707 E:720 ||| JJ
functions ||| S:720 E:729 ||| NNS
,  ||| S:729 E:731 ||| ,
particularly  ||| S:731 E:744 ||| RB
gastric  ||| S:744 E:752 ||| JJ
emptying ||| S:752 E:760 ||| NN
,  ||| S:760 E:762 ||| ,
and  ||| S:762 E:766 ||| CC
gastrointestinal  ||| S:766 E:783 ||| JJ
symptoms ||| S:783 E:791 ||| NNS
.  ||| S:791 E:793 ||| .
The  ||| S:793 E:797 ||| DT
effects  ||| S:797 E:805 ||| NNS
of  ||| S:805 E:808 ||| IN
drugs  ||| S:808 E:814 ||| NNS
and  ||| S:814 E:818 ||| CC
hormones  ||| S:818 E:827 ||| NNS
that  ||| S:827 E:832 ||| WDT
affect  ||| S:832 E:839 ||| VBP
glycemia  ||| S:839 E:848 ||| VBN
on  ||| S:848 E:851 ||| IN
gastrointestinal  ||| S:851 E:868 ||| JJ
sensorimotor  ||| S:868 E:881 ||| JJ
functions  ||| S:881 E:891 ||| NNS
were  ||| S:891 E:896 ||| VBD
also  ||| S:896 E:901 ||| RB
evaluated ||| S:901 E:910 ||| VBN
.  ||| S:910 E:912 ||| .
Acute  ||| S:912 E:918 ||| FW
severe  ||| S:918 E:925 ||| FW
hyperglycemia  ||| S:925 E:939 ||| FW
delayed  ||| S:939 E:947 ||| FW
gastric  ||| S:947 E:955 ||| FW
emptying  ||| S:955 E:964 ||| FW
relative  ||| S:964 E:973 ||| JJ
to  ||| S:973 E:976 ||| TO
euglycemia  ||| S:976 E:987 ||| VB
in  ||| S:987 E:990 ||| IN
type  ||| S:990 E:995 ||| NN
1  ||| S:995 E:997 ||| CD
diabetes ||| S:997 E:1005 ||| NN
;  ||| S:1005 E:1007 ||| :
the  ||| S:1007 E:1011 ||| DT
corresponding  ||| S:1011 E:1025 ||| JJ
effects  ||| S:1025 E:1033 ||| NNS
in  ||| S:1033 E:1036 ||| IN
type  ||| S:1036 E:1041 ||| NN
2  ||| S:1041 E:1043 ||| CD
diabetes  ||| S:1043 E:1052 ||| NNS
are  ||| S:1052 E:1056 ||| VBP
unknown ||| S:1056 E:1063 ||| JJ
.  ||| S:1063 E:1065 ||| .
Limited  ||| S:1065 E:1073 ||| JJ
evidence  ||| S:1073 E:1082 ||| NN
suggests  ||| S:1082 E:1091 ||| VBZ
that  ||| S:1091 E:1096 ||| IN
even  ||| S:1096 E:1101 ||| RB
mild  ||| S:1101 E:1106 ||| JJ
hyperglycemia  ||| S:1106 E:1120 ||| NNS
( ||| S:1120 E:1121 ||| -LRB-
8  ||| S:1121 E:1123 ||| CD
mmol ||| S:1123 E:1127 ||| CD
/ ||| S:1127 E:1128 ||| CD
L ||| S:1128 E:1129 ||| NNP
)  ||| S:1129 E:1131 ||| -RRB-
can  ||| S:1131 E:1135 ||| MD
delay  ||| S:1135 E:1141 ||| VB
gastric  ||| S:1141 E:1149 ||| JJ
emptying  ||| S:1149 E:1158 ||| NN
in  ||| S:1158 E:1161 ||| IN
type  ||| S:1161 E:1166 ||| NN
1  ||| S:1166 E:1168 ||| CD
diabetes ||| S:1168 E:1176 ||| NN
.  ||| S:1176 E:1178 ||| .
Long-term  ||| S:1178 E:1188 ||| JJ
hyperglycemia  ||| S:1188 E:1202 ||| NN
is  ||| S:1202 E:1205 ||| VBZ
an  ||| S:1205 E:1208 ||| DT
independent  ||| S:1208 E:1220 ||| JJ
risk  ||| S:1220 E:1225 ||| NN
factor  ||| S:1225 E:1232 ||| NN
for  ||| S:1232 E:1236 ||| IN
delayed  ||| S:1236 E:1244 ||| JJ
gastric  ||| S:1244 E:1252 ||| JJ
emptying  ||| S:1252 E:1261 ||| NN
in  ||| S:1261 E:1264 ||| IN
type  ||| S:1264 E:1269 ||| NN
1  ||| S:1269 E:1271 ||| CD
diabetes ||| S:1271 E:1279 ||| NN
.  ||| S:1279 E:1281 ||| .
There  ||| S:1281 E:1287 ||| EX
is  ||| S:1287 E:1290 ||| VBZ
little  ||| S:1290 E:1297 ||| JJ
evidence  ||| S:1297 E:1306 ||| NN
that  ||| S:1306 E:1311 ||| WDT
delayed  ||| S:1311 E:1319 ||| VBD
gastric  ||| S:1319 E:1327 ||| JJ
emptying  ||| S:1327 E:1336 ||| NN
causes  ||| S:1336 E:1343 ||| VBZ
hypoglycemia  ||| S:1343 E:1356 ||| NN
in  ||| S:1356 E:1359 ||| IN
diabetes  ||| S:1359 E:1368 ||| NN
and  ||| S:1368 E:1372 ||| CC
no  ||| S:1372 E:1375 ||| DT
evidence  ||| S:1375 E:1384 ||| NN
that  ||| S:1384 E:1389 ||| IN
improved  ||| S:1389 E:1398 ||| JJ
control  ||| S:1398 E:1406 ||| NN
of  ||| S:1406 E:1409 ||| IN
glycemia  ||| S:1409 E:1418 ||| FW
improves  ||| S:1418 E:1427 ||| FW
gastric  ||| S:1427 E:1435 ||| FW
emptying  ||| S:1435 E:1444 ||| FW
or  ||| S:1444 E:1447 ||| FW
vice  ||| S:1447 E:1452 ||| FW
versa ||| S:1452 E:1457 ||| FW
.  ||| S:1457 E:1459 ||| .
Glucagon-like  ||| S:1459 E:1473 ||| NNP
peptide-1  ||| S:1473 E:1483 ||| NNP
agonists  ||| S:1483 E:1492 ||| NN
but  ||| S:1492 E:1496 ||| CC
not  ||| S:1496 E:1500 ||| RB
dipeptidylpeptidase-4  ||| S:1500 E:1522 ||| FW
inhibitors  ||| S:1522 E:1533 ||| FW
given  ||| S:1533 E:1539 ||| FW
acutely  ||| S:1539 E:1547 ||| FW
delay  ||| S:1547 E:1553 ||| FW
gastric  ||| S:1553 E:1561 ||| FW
emptying ||| S:1561 E:1569 ||| FW
,  ||| S:1569 E:1571 ||| ,
but  ||| S:1571 E:1575 ||| CC
tachyphylaxis  ||| S:1575 E:1589 ||| NNS
may  ||| S:1589 E:1593 ||| MD
occur ||| S:1593 E:1598 ||| VB
.  ||| S:1598 E:1600 ||| .
Although  ||| S:1600 E:1609 ||| IN
acute  ||| S:1609 E:1615 ||| JJ
severe  ||| S:1615 E:1622 ||| JJ
and  ||| S:1622 E:1626 ||| CC
chronic  ||| S:1626 E:1634 ||| JJ
hyperglycemia  ||| S:1634 E:1648 ||| NN
can  ||| S:1648 E:1652 ||| MD
delay  ||| S:1652 E:1658 ||| VB
gastric  ||| S:1658 E:1666 ||| JJ
emptying ||| S:1666 E:1674 ||| NN
,  ||| S:1674 E:1676 ||| ,
there  ||| S:1676 E:1682 ||| EX
is  ||| S:1682 E:1685 ||| VBZ
limited  ||| S:1685 E:1693 ||| JJ
evidence  ||| S:1693 E:1702 ||| NN
that  ||| S:1702 E:1707 ||| WDT
delayed  ||| S:1707 E:1715 ||| VBD
gastric  ||| S:1715 E:1723 ||| JJ
emptying  ||| S:1723 E:1732 ||| NN
is  ||| S:1732 E:1735 ||| VBZ
an  ||| S:1735 E:1738 ||| DT
independent  ||| S:1738 E:1750 ||| JJ
risk  ||| S:1750 E:1755 ||| NN
factor  ||| S:1755 E:1762 ||| NN
for  ||| S:1762 E:1766 ||| IN
impaired  ||| S:1766 E:1775 ||| JJ
glycemic  ||| S:1775 E:1784 ||| JJ
control  ||| S:1784 E:1792 ||| NN
or  ||| S:1792 E:1795 ||| CC
hypoglycemia  ||| S:1795 E:1808 ||| NN
in  ||| S:1808 E:1811 ||| IN
diabetes ||| S:1811 E:1819 ||| NN
.  ||| S:1819 E:1821 ||| .
The  ||| S:1821 E:1825 ||| DT
impact  ||| S:1825 E:1832 ||| NN
of  ||| S:1832 E:1835 ||| IN
improved  ||| S:1835 E:1844 ||| JJ
glycemic  ||| S:1844 E:1853 ||| JJ
control  ||| S:1853 E:1861 ||| NN
on  ||| S:1861 E:1864 ||| IN
gastric  ||| S:1864 E:1872 ||| JJ
emptying  ||| S:1872 E:1881 ||| NN
and  ||| S:1881 E:1885 ||| CC
vice  ||| S:1885 E:1890 ||| NN
versa  ||| S:1890 E:1896 ||| NN
in  ||| S:1896 E:1899 ||| IN
diabetes  ||| S:1899 E:1908 ||| NN
is  ||| S:1908 E:1911 ||| VBZ
unknown ||| S:1911 E:1918 ||| JJ
.  ||| S:1918 E:1920 ||| .
